FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2548436228> ?p ?o ?g. }

• W2548436228 abstract "Abstract Abstract 2186 Background: Ponatinib (AP24534) is identified as a pan-BCR-ABL inhibitor that potently inhibits the T315I gatekeeper mutant, and has advanced into clinical development for the treatment of refractory or resistant CML (Chronic Myeloid Leukemia). Ponatinib potently inhibited in vitro proliferation of Ba/F3 cells expressing BCR-ABL T315I mutation (IC 50; 11 nM). In PACE (Ponatinib Ph+ ALL and CML Evaluation) clinical trial indicated that 57% had CCyR (complete cytogenetical response), and 47% had MMR (major molecular response) in CML-chronic phase with T315I mutation. Ponatinib has substantial activity in heavily pretreated patients and those with refractory T315I mutation. However, approximately one third of ponatinib-treated patients had moderate to severe thrombocytopenia (J.E. Cortes et al. 2011 ASH Annual Meeting). The mechanism of ponatinib-induced thrombocytopenia remains unknown. In this study, we evaluated the effects of ponatinib on megakaryocytic progenitor cells, megakaryocytopoiesis, megakaryocyte and platelet production in mice. Method: All animal procedures were approved by the Institutional Animal Care and Use Committee of Iwate Medical University. Male ddY mice at 8 weeks of age were used in all experiments. We studied in vitro culture of megakaryocytic colonies (CFU-Meg), megakaryocyte ploidy analyses in vitro culture and proplatelet formation (PPF) assay in vitro. Murine bone marrow cells were cultured in methylcellulose with mIL-3, mIL-6 and TPO at 37°C in 5% CO2 and 20% O2 for 7 days in the presence of ponatinib (0.01, 0.1, 1, 10, 100 nM). PPF: Murine megakarocytes were partially purified from bone marrow cells using BSA gradient. They were plated in 96 micro-well culture plates (300 megakaryocyte/well) and cultured in IMDM, supplemented with 1% ITS-G (serum-free medium) in the presence of ponatinib (0.01, 0.1, 1, 10, 100 nM), at 37°C in 5% CO2and 20% O2. After 24 hr incubation, the megakaryocytes with proplatelets in each well were counted. Activated Rho and activated Rac in murine platelets were measured by the Western blot using Rhotekin-binding domain (RBD) beads and PAK-PBD Affinity beads respectively. The phosphorylation of Lyn (Src family kinase) in murine platelets was also evaluated by the Western blots. Results: CFU-Megs did not decrease significantly at 0.01, 0.1, 1, 10 and 100 nM (31.8 +/− 1.4 to 42.3 +/− 2.4 cells) and decreased significantly (17.0 +/− 1.6 cells p<0.01) at 1000 nM of ponatinib. PPF were decreased significantly at 0.1, 1, 10, 100 nM ponatinib (0 nM: 26.4 ± 0.8 %, 0.1 nM: 19.2 ± 1.7% p<0.05, 1 nM: 19.4 ± 2.1 % p<0.05, 10 nM: 17.9 ± 1.1% p<0.01, 100 nM: 12.5 ± 1.1 % p<0.001, 1000 nM: 11.6 ± 0.9 % p<0.001). The decreases in PPF were cancelled significantly by the addition of Y27632, Rho-associate kinase ROCK inhibitor (ponatinib 10 nM; 17.9 ± 1.1%, ponatinib 10 nM + Y27632 10μM; 29.8 ± 1.7% p<0.001, ponatinib 100 nM; 12.5 ± 1.1%, ponatinib 100 nM + Y27632 10μM; 19.3 ± 1.4% p<0.001). There was no difference in DNA ploidy of cultured megakaryocytes in the presence of ponatinib (0.01 to 100 nM). Next we have tried to understand the precise role of Rho/Rock and Rac pathways in platelets. Our data showed that Rho was upregulated and that activated Rac was downregulated at 50 nM of ponatinib. Ponatinib reduced the levels of phosphorylated Lyn (p-Lyn). Discussion and Conclusion: The Rho/ROCK pathway was reported to be negative regulators (Blood 2007 109; 4229) and positive regulators (Blood 2007 110; 3637) in PPF. Ponatinib induced thrombocytopenia might not be due to the inhibition of megakaryocyte colony formations but the inhibition of PPF of megakaryocytes via pathways including Rho/Rock and Rac. Disclosures: No relevant conflicts of interest to declare." @default.
• W2548436228 created "2016-11-11" @default.
• W2548436228 creator A5012499237 @default.
• W2548436228 creator A5015528767 @default.
• W2548436228 creator A5021620288 @default.
• W2548436228 creator A5034065557 @default.
• W2548436228 creator A5034185227 @default.
• W2548436228 creator A5047773258 @default.
• W2548436228 creator A5057713792 @default.
• W2548436228 creator A5063909273 @default.
• W2548436228 creator A5076101717 @default.
• W2548436228 creator A5085330864 @default.
• W2548436228 creator A5085346093 @default.
• W2548436228 creator A5086856159 @default.
• W2548436228 date "2012-11-16" @default.
• W2548436228 modified "2023-09-29" @default.
• W2548436228 title "Ponatinib Induced Thrombocytopenia Might Inhibit Proplatelet Formation of Megakaryocytes Via the Pathways Including Rho/Rock and Rac." @default.
• W2548436228 doi "https://doi.org/10.1182/blood.v120.21.2186.2186" @default.
• W2548436228 hasPublicationYear "2012" @default.
• W2548436228 type Work @default.
• W2548436228 sameAs 2548436228 @default.
• W2548436228 citedByCount "0" @default.
• W2548436228 crossrefType "journal-article" @default.
• W2548436228 hasAuthorship W2548436228A5012499237 @default.
• W2548436228 hasAuthorship W2548436228A5015528767 @default.
• W2548436228 hasAuthorship W2548436228A5021620288 @default.
• W2548436228 hasAuthorship W2548436228A5034065557 @default.
• W2548436228 hasAuthorship W2548436228A5034185227 @default.
• W2548436228 hasAuthorship W2548436228A5047773258 @default.
• W2548436228 hasAuthorship W2548436228A5057713792 @default.
• W2548436228 hasAuthorship W2548436228A5063909273 @default.
• W2548436228 hasAuthorship W2548436228A5076101717 @default.
• W2548436228 hasAuthorship W2548436228A5085330864 @default.
• W2548436228 hasAuthorship W2548436228A5085346093 @default.
• W2548436228 hasAuthorship W2548436228A5086856159 @default.
• W2548436228 hasConcept C109159458 @default.
• W2548436228 hasConcept C202751555 @default.
• W2548436228 hasConcept C203014093 @default.
• W2548436228 hasConcept C2776958478 @default.
• W2548436228 hasConcept C2777583451 @default.
• W2548436228 hasConcept C2777918643 @default.
• W2548436228 hasConcept C2778729363 @default.
• W2548436228 hasConcept C2779536868 @default.
• W2548436228 hasConcept C2779705218 @default.
• W2548436228 hasConcept C2780381907 @default.
• W2548436228 hasConcept C28328180 @default.
• W2548436228 hasConcept C502942594 @default.
• W2548436228 hasConcept C54355233 @default.
• W2548436228 hasConcept C71924100 @default.
• W2548436228 hasConcept C86803240 @default.
• W2548436228 hasConcept C95444343 @default.
• W2548436228 hasConceptScore W2548436228C109159458 @default.
• W2548436228 hasConceptScore W2548436228C202751555 @default.
• W2548436228 hasConceptScore W2548436228C203014093 @default.
• W2548436228 hasConceptScore W2548436228C2776958478 @default.
• W2548436228 hasConceptScore W2548436228C2777583451 @default.
• W2548436228 hasConceptScore W2548436228C2777918643 @default.
• W2548436228 hasConceptScore W2548436228C2778729363 @default.
• W2548436228 hasConceptScore W2548436228C2779536868 @default.
• W2548436228 hasConceptScore W2548436228C2779705218 @default.
• W2548436228 hasConceptScore W2548436228C2780381907 @default.
• W2548436228 hasConceptScore W2548436228C28328180 @default.
• W2548436228 hasConceptScore W2548436228C502942594 @default.
• W2548436228 hasConceptScore W2548436228C54355233 @default.
• W2548436228 hasConceptScore W2548436228C71924100 @default.
• W2548436228 hasConceptScore W2548436228C86803240 @default.
• W2548436228 hasConceptScore W2548436228C95444343 @default.
• W2548436228 hasLocation W25484362281 @default.
• W2548436228 hasOpenAccess W2548436228 @default.
• W2548436228 hasPrimaryLocation W25484362281 @default.
• W2548436228 hasRelatedWork W198448027 @default.
• W2548436228 hasRelatedWork W1999395799 @default.
• W2548436228 hasRelatedWork W2025579499 @default.
• W2548436228 hasRelatedWork W2341341631 @default.
• W2548436228 hasRelatedWork W2352697229 @default.
• W2548436228 hasRelatedWork W2373933542 @default.
• W2548436228 hasRelatedWork W2376072165 @default.
• W2548436228 hasRelatedWork W2411790851 @default.
• W2548436228 hasRelatedWork W2470646853 @default.
• W2548436228 hasRelatedWork W2529971935 @default.
• W2548436228 hasRelatedWork W2530321526 @default.
• W2548436228 hasRelatedWork W2538455610 @default.
• W2548436228 hasRelatedWork W2547251167 @default.
• W2548436228 hasRelatedWork W2557014216 @default.
• W2548436228 hasRelatedWork W2559877690 @default.
• W2548436228 hasRelatedWork W2578953974 @default.
• W2548436228 hasRelatedWork W2592309045 @default.
• W2548436228 hasRelatedWork W2732231164 @default.
• W2548436228 hasRelatedWork W2980249018 @default.
• W2548436228 hasRelatedWork W656370487 @default.
• W2548436228 isParatext "false" @default.
• W2548436228 isRetracted "false" @default.
• W2548436228 magId "2548436228" @default.
• W2548436228 workType "article" @default.